Novo Nordisk's newly approved weight-loss pill version of Wegovy will be a test case for the fast-growing cash-paying ...

The U.S. Food and Drug Administration's approval of an oral version of Novo Nordisk's weight-loss drug Wegovy could ...

US-listed shares of Novo jumped 8 per cent and Lilly fell 1 per cent in extended trading after the approval announcement ...

Morning Brief host Julie Hyman tracks several of the day's top trending stock tickers, including the results of Eli Lilly's ...

It gives the Danish drugmaker a leg up in the race to market a potent oral medication for shedding pounds as it looks to ...

A month after acquiring obesity biotech Metsera, Pfizer's expanding in the weight loss drug market after signing a licensing ...

High mileage on a 6.6 Duramax is less about a single scary number on the odometer and more about how that number lines up ...

Major stock indexes ended mixed Thursday, with the Dow Jones Industrial Average and S&P 500 closing at record highs but the ...

Eli Lilly and Novo Nordisk — the dominant players in obesity drug development — each submitted a new weight-loss drug to the ...

U.S. pharmaceutical company Eli Lilly & Co. (LLY) says that its new obesity pill helped patients maintain the majority of ...